Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 21 May 2022 |
2 | Reply to Exam Report (MIS-R) | 15 Feb 2023 |
3 | Revival of Application/Normal | 18 Apr 2023 |
4 | Documents in support of Show cause Hearing (SCH) | 20 Mar 2024 |
5 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 02 Apr 2024 |
6 | Journal Copy | 26 Nov 2024 |
1 | EXAMINATION REPORT | 14051288 | 07 Sep 2022 | |
2 | Hearing Notice (Show Cause) | 17546175 | 26 Feb 2024 | |
3 | Hearing Notice (Show Cause) | 18195661 | 21 May 2024 | |
4 | Adjourned Notice | 18466168 | 09 Jul 2024 | |
5 | Hearing Notice (Show Cause) | 18955830 | 07 Oct 2024 | |
6 | Tribunal Accepted Notice for : 5457060 | 19134344 | 6974583 | 12 Nov 2024 |
Trademark was applied on 21 May 2022 with IP India.
Proprietor of Clindacin ovules is BLISS GVS PHARMA.
Class(es) in which the trademark was applied to is 5.
Status of Clindacin ovules is Accepted & Advertised.
Application number alloted to the trademark is 5457060.
Innovative Consultants is the Trademark agent/attorney.
Trademark has been filed in the following category:
DEVICE